Cancer Health Treatment Update What Is an Antibody-Drug Conjugate? Antibody-drug conjugates are targeted agents that package cancer drugs for special delivery to tumor cells. Targeted Immunotherapy For Deadly Prostate Cancer Shows Promise Antibody-drug conjugate could be a step toward selective treatment for neuroendocrine prostate cancer. Liver Cancer Is Rising Fastest in Rural America Areas with lower population density have not seen the same slowdown as urban areas. Can Algorithms Nudge Oncologists to Have Better Conversations? Machine-learning prompts could encourage oncologists to help patients with high-risk cancers make informed decisions. News From the ESMO Virtual Congress See all our reports from Europe's biggest cancer conference. Promising COVID-19 Vaccine News Coronavirus vaccines from Pfizer/BioNTech and Moderna and the National Institutes of Health are 95% effective. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For other news about the new coronavirus, visit COVID Health. Cancer Health Fall 2020 Check out our latest print edition! Advertisement Newsfeed The Truth About the Biden Cancer Initiative COVID-19 Vaccine Is 95% Effective, Pfizer Says Can Algorithms Nudge Oncologists to Have Better Conversations? Older Adults Feel Lonelier Due to COVID-19 Blog: Food and Drug Administration (FDA) Breast Cancer Screening: Thermogram No Substitute for Mammogram FDA Issues Alert About Tecentriq Plus Paclitaxel for Breast Cancer FDA Approves Onureg for Acute Myeloid Leukemia FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma Newsfeed The Truth About the Biden Cancer Initiative COVID-19 Vaccine Is 95% Effective, Pfizer Says Can Algorithms Nudge Oncologists to Have Better Conversations? Older Adults Feel Lonelier Due to COVID-19 Blog: Food and Drug Administration (FDA) Breast Cancer Screening: Thermogram No Substitute for Mammogram FDA Issues Alert About Tecentriq Plus Paclitaxel for Breast Cancer FDA Approves Onureg for Acute Myeloid Leukemia FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: